- Comparison of Dietary and Lifestyle Habits Among Stage III and Metastatic Colorectal Cancer Patients: Findings from CALGB 89803 and CALGB 80405Katherine Van Loon
Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA Electronic address
Clin Colorectal Cancer 12:95-102. 2013..Using data from 2 large National Cancer Institute-sponsored clinical trials, we report on the dietary and lifestyle practices of patients receiving therapy for stage III colon or metastatic colorectal cancer...
- Counterpoint: Adjuvant therapy in stage II colon cancer: pain not justified by the gainKatherine Van Loon
Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115, USA
J Natl Compr Canc Netw 10:1379-86. 2012..Given what is now known, the viewpoint is that the aggregate data do not support adjuvant therapy for patients with normal-risk stage II colon cancer...
- Adjuvant treatment of colon cancer: what is next?Katherine Van Loon
Division of Hematology Oncology, Department of Medicine, University of California San Francisco, San Francisco, California 94115, USA
Curr Opin Oncol 23:403-9. 2011..In addition, we examine how results of these trials have shaped our knowledge and outline directions for future research...